BriaCell Therapeutics Corp.

Immuno-oncology biotech developing targeted immunotherapies for breast and other cancers

What BriaCell Therapeutics does

BriaCell Therapeutics develops treatments that help the body's immune system find and attack cancer. Its lead candidate, Bria-IMT, is a targeted immunotherapy for end-stage breast cancer and is in Phase 3 clinical trials. It is also developing an off-the-shelf personalized immunotherapy and a protein drug that boosts the immune response against tumors.

How BriaCell Therapeutics makes money

BriaCell is still developing its drugs, so it does not yet sell products. It aims to earn money by commercializing its therapies once they are approved, using licensed technology and research partnerships to support that work.

Products & services

• Bria-IMT
• Bria-OTS
• Bria-OTS+
• Soluble CD80